Cure Pharmaceutical Holding Corp. (IFIN)
NYSE NYSE Primary 
XKUW Summary
IFIN Chart
Cure Pharmaceutical Holding Corp. (IFIN) FAQ
What does "Delisted" mean?
What was the last recorded dividend?
How long did the company pay dividends?
Were there any stock splits?
What was the last known trading price?
Cure Pharmaceutical Holding Corp. Profile
| Trading Companies & Distributors Industry | Industrials Sector | Alexander Edgarov CEO | NYSE Exchange | G47862100 CUSIP |
| US Country | 2 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
InFinT Acquisition Corporation is a company primarily engaged in preparing for business combinations, specifically focusing on the financial technology sector. Established in 2021 and headquartered in New York, New York, the firm has positioned itself as a vehicle for share exchange, share reconstruction, amalgamation, or similar business combination activities with one or more businesses. Its target regions encompass a global scope, including North America, Asia, Latin America, Europe, and Israel. Although it currently does not have significant operations, its strategic intent is clear—to forge connections with businesses in the financial technology segments across its targeted geographies.
Products and Services
InFinT Acquisition Corporation, due to its nature as a company poised for mergers and acquisitions, particularly within the financial technology industry, does not offer traditional products or services. Instead, its activities can be categorized under strategic mergers and acquisition initiatives:
- Share Exchange: Facilitates transactions in which shares of one company are exchanged for those of another, as a means of merging businesses.
- Share Reconstruction and Amalgamation: Engages in the restructuring of company shares and the amalgamation of companies to form a single entity, aiming at strategic growth or consolidation within the financial technology sector.
